Saturday, September 18, 2021
wellness India Expo
Home Tags Dr Kiran Mazumdar Shaw

Tag: Dr Kiran Mazumdar Shaw

Biocon Biologics & Serum Institute Life Sciences announce strategic alliance

BBL will have access to 100 million doses of vaccines annually and commercialization rights of the SILS vaccine portfolio for global markets. SILS to receive ~15% stake in BBL at a post-money valuation of ~$4.9 billion......................

Advancements in digital technology critical to advancements in clinical trials

As per experts, the digital-enabled regulatory flexibility during the pandemic that had helped bring drugs faster to market needs to continue.....................

Reimagining India’s Health System – The Lancet Citizens’ Commission launched

The launch of the initiative aims at developing a citizens’ roadmap to achieving universal health coverage. The commission will be the first participatory, country-wide report of its scale to be developed.........................

COVID-19: DBT’s NBRIC emerges as key convergence platform to fuel Made-in-India...

Within a month of its inception, the National Biomedical Resources Indigenization Consortium constituted by the Department of Biotechnology, has seen active engagement from several major stakeholders of Indian biomedical resources innovation community

Syngene International & BIRAC set up Centre for Advanced Protein Studies

The Centre has been set up at Syngene’s campus in Bengaluru by the Biotechnology Industry Research Assistance Council (BIRAC) and will host a state-of-the-art GLP accredited analytical laboratory. The collaboration a part of National Biopharma Mission.............

Science & technology play a central role in societal development

LMSAI- Harvard University collaborated with the office of Scientific Adviser to Government of India and NITI Aayog to host annual India symposium on ‘Science & Society’ on 4th April at New Delhi..................

India showcases its biotech power at BIO Boston

The world’s largest gathering of the biotechnology industry witnessed a record 17,000 participants over the 4 days of the event held at Boston in the United States of America...................

Biocon & Mylan’s biosimilar ‘Trastuzumab’ gets approval from Brazilian regulator

Co-developed by Biocon and Mylan, this is the first biosimilar Trastuzumab to be approved in Brazil and is indicated for the treatment of overexpressing HER2­positive metastatic breast cancer. The product will be marketed by the Libbs Farmaceutica........

BIRAC celebrates its 5th birthday amid resolve to make India a...

The intense discussions at the 2-day event to celebrate the 5th foundation day of the Biotechnology Research Assistance Council, were focused around the theme “[email protected]: Impacting the Biotech Ecosystem”........

ABLE selects BEST student entrepreneurial teams for 2016

ABLE announces BEST 2016 winners, the annual list of five teams comprising of young post graduate teams who wish to pursue the spirit of biotech innovation and business......